Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 5 Breast Neoplasms 3 Neoadjuvant Therapy 1 BRCA-Mutated Breast Carcinoma 1

Interventions

famitinib 1 enzalutamide 1 apalutamide 1 Prednisolone 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Neoadjuvant Therapy 1 Drug Therapy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoadjuvant Therapy × famitinib × Clear all

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Fudan University

Phase 3 Recruiting

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡